CCMH
SGNT

Cornerstone Capital Management Holdings’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-138,700
Closed -$2.08M – 1549
2016
Q2 		$2.08M Buy
+138,700
New +$1.78M 0.02% 718
2016
Q1 		– Sell
-7,600
Closed -$121K – 1622
2015
Q4 		$121K Sell
7,600
-113,100
-94% -$1.78M ﹤0.01% 1288
2015
Q3 		$1.85M Buy
120,700
+42,400
+54% +$916K 0.02% 741
2015
Q2 		$1.9M Buy
78,300
+33,300
+74% +$798K 0.02% 731
2015
Q1 		$1.05M Sell
45,000
-22,502
-33% -$596K 0.01% 875
2014
Q4 		$1.7M Buy
67,502
+6,202
+10% +$182K 0.02% 757
2014
Q3 		$1.91M Sell
61,300
-59,900
-49% -$1.62M 0.02% 703
2014
Q2 		$3.13M Buy
121,200
+55,400
+84% +$1.23M 0.03% 550
2014
Q1 		$1.54M Sell
65,800
-38,300
-37% -$838K 0.02% 776
2013
Q4 		$2.64M Buy
104,100
+29,500
+40% +$666K 0.03% 575
2013
Q3 		$1.52M Buy
74,600
+24,300
+48% +$541K 0.02% 723
2013
Q2 		$1.06M Buy
+50,300
New +$899K 0.01% 794

Cornerstone Capital Management Holdings's SGNT Position: Q3 2016 in Review

Cornerstone Capital Management Holdings sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 138,700 shares — an estimated $2.08M sold.

Cornerstone Capital Management Holdings first reported a position in SGNT in Q2 2013 and held it in 12 quarters. The position peaked at $3.13M in Q2 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Cornerstone Capital Management Holdings reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 138,700 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2.08M.
  • Cornerstone Capital Management Holdings first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Cornerstone Capital Management Holdings's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.13M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2016, filed 16 Nov 2016.